Drugmakers Set to Raise US Prices on at Least 500 Drugs in January

Drugmakers including Pfizer, Sanofi and Takeda Pharmaceutical plan to raise prices in the United States on more than 500 drugs in early January, according to data analyzed by healthcare research firm 3 Axis Advisors.

Excluding different doses and formulations, more than 140 brands of drugs will have their prices raised next month, the data showed.

Worries are also growing about fresh disruption to supply chains from a prolonged Middle East conflict, with shippers forced to halt or reroute traffic from the Red Sea, the world's main East-West trade route.

Three companies including GlaxoSmithKline, which last week said it would cut prices on some asthma, herpes and anti-epileptic drugs for 2024, are also expected to lower prices on at least 15 drugs in January, according to the data.

Source: MEDspace